Clinical Trial Update: Open Label Study of Pharmacokinetics and Safety of Dose of Adefovir Dipivoxil in Children and Adolescents With HBV [Phase 1, Phase 2]

View source ↗

Summary

Open-label pharmacokinetics and safety study of adefovir dipivoxil in children and adolescents with hepatitis B has completed, providing PK and safety data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Hepsera (adefovir dipivoxil)

Snippet

Sponsor: Gilead Sciences | Conditions: Hepatitis B | Phase 1, Phase 2 | Status: COMPLETED